A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

GENERIC NAME  
Ofloxacin Autosubstitution with Levofloxacin
Omeprazole Pantoprazole will be automatically substituted for other proton pump inhibitors. When administering PPIs  via feeding tubes auto substitute Lansoprazole Solutabs.

        Pantoprazole (Protonix), injection and oral, is the proton pump inhibitor of choice, with automatic substitution for omeprazole (Prilosec), rabeprazole (Aciphex),  Lansoprazole (Prevacid), and other oral proton pump inhibitors unless the physician has checked the dispense as written block.

Dosing Equivalence (mg)

Lansoprazole

(Prevacid)

Esomeprazole

(Nexium)

Omeprazole

(Prilosec)

Rabeprazole

(Aciphex)

Pantoprazole

(Protonix)

30 qd

20 qd

20 qd

20 qd

20 qd

30 qd

40 qd

40 qd

20 qd

40 qd

30 bid

20-40 bid

20-40 bid

20 bid

40 bid

Lanoprazole Solutabs, 15 mg or 30 mg, may be mixed with water and placed down a very small bore pediatric feeding tube. The granules do not clump or adhere to the tube.

Lanoprazole

Omeprazole

1-11 years

<= 30 kg

15 mg qd

>= 2 years

< 20 kg

10 mg qd

 

> 30 kg

30 mg qd

 

>=20 kg

20 mg qd

12-17 years

Non erosive GERD

15 mg qd

 

 

 

 

Erosive GERD

30 mg qd

 

 

 

Pantoprazole IV Criteria for use

        Criteria for use of IV Proton Pump Inhibitors (PPIs) are list below.  If a patient does not meet criteria the pharmacist will call the physician and/or leave a chart note recommending conversion to oral therapy.

  • Initial treatment of patients with active upper GI tract bleeding, until they can tolerate oral therapy, usually after three days of therapy.
  • Initial treatment of patients with Zollinger-Ellison syndrome, until they can tolerate oral therapy
  • Stress-ulcer prophylaxis for critical care patients
  • Patients who require PPI therapy who can not tolerate oral or NG PPI therapy

        Patients on IV proton pump inhibitors will have an order entered for the oral route allowing the nurse to use the oral route when the patient is tolerating oral therapy. Proton pump inhibitors may be given by the oral route if the patient does not have active gastrointestinal bleeding, malabsorption syndrome, short bowel syndrome, severe diarrhea, uncontrolled nausea and vomiting, continuous nasogastric suctioning, and is not at risk for aspiration. 

 

Oncology Education Links
Ondansetron Injection Formulary
Ondansetron ODR Tablet  
Opioid Equivalance Chart  
   
   

Home

Hit Counter